Telehealth and Telecare News since 2005 ...

Beyond his company, James Batchelor (or James Batchelor MBE, as we should now call him!) tirelessly campaigns to alleviate loneliness and isolation among older people, mentors socially focused ...

Hims & Hers expands to Ireland, France, and Germany, and adds to UK. Announced yesterday, the ambitious strategic acquisition of Zava, a similar online direct to consumer provider of telemedicine ...

Your Editor recommends grabbing lunch or a cuppa for these lengthy reads/views: Flawed Federal Programs Maroon Rural Americans in Telehealth Blackouts. This is mostly about the billions spent in ‘last ...

Midi Health broadens mid-life women’s health into longevity–covered by some insurance. Midi Health, which targets women in their middle years (a limiting definition, as this Editor will explain), is ...

Another review/meta-analysis confirms that GLP-1 weight off doesn’t stay off. A University of Oxford systemic review and meta-analysis of 130 full texts, distilled to 11 studies with 6,370 ...

One of our Perspectives contributors, Yosi Health, is seeking candidates for two positions:. Demand Generation Manager . This role combines lead generation with marketing analysis, coordination with ...

Breaking up is hard to do. But should be done if UHG wants to survive and thrive. Our proposition: UnitedHealth Group has become a victim of its own giantism, conflicts, and focus on financials–and ...

Leading our news with a short, heartwarming story. The White House’s proposed discretionary budget for FY 2026 calls for an increase of nearly $2.2 billion in funding for the EHR program as a “top ...

Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...

The Masimo website goes offline–coinciding with their investor meeting. When this Editor posted an article on former Masimo CEO Joseph Kiani’s “beneficial ownership” SEC filing (Schedule G/A, for ...

Medical device company Masimo may not be able to rid itself entirely of its meddlesome former CEO, Joe Kiani. In fact, if a court awards him the shares exercised under his various employment ...